The Effect of Respiratory Muscle Warm-up on Pulmonary Diffusion Capacity in Athletes

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-24
SponsorEmre Karaduman

About this trial

Several studies suggest that inspiratory muscle warm-up (IMW) could potentially affect exercise performance; however, its mechanistic basis is still unclear. The aim of this study was to examine the effect of IMW on lung diffusing capacity for carbon monoxide, cardiorespiratory, perceptual and performance outcomes in elite athletes from different disciplines.

The aim of this study is to evaluate the effects of IMW on diffusion capacity for carbon monoxide, cardiorespiratory, perceptual and performance outcomes during high-intensity exercise in elite athletes from different disciplines. The study will be conducted using a randomized, placebo-controlled, double-blind and crossover study experimental design involving 35 athletes from various sports disciplines, including endurance, strength, skill-based, and mixed disciplines.

Participants will attend the laboratory on four separate occasions. During the first visit, they will be informed about the study and familiarized with the application and measurement procedures. In the second visit, a general warm-up will be performed. During the third and fourth visits, IMW (IMW40% or IMW placebo) protocols will be applied in addition to the general warm-up. Measurements of DLCO, pulmonary function tests, respiratory muscle strength, and gas analysis during maximal aerobic exercise will be collected both before and after the warm-up protocols.

Eligibility criteria

Qualifiers

Age between 18-24 years.

A training history of at least six years.

Regular training frequency of at least four sessions per week.

Disqualifiers

History of smoking.

History of physical disability or acute respiratory or cardiovascular disease within the past three months.

Diagnosis of SARS-CoV-2 within the past three months.

Pulmonary function measurements outside the normal clinical range (≤ 80%).

Trial design

Treatments tested in this trial

  • Inspiratory muscle warm-up
  • General warm-up (Control)
  • Inspiratory muscle warm-up placebo (IMW %15)

Treatment groups

35 Participants
are divided into 3 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Emre Karaduman

Lead sponsor

Ondokuz Mayıs University

Sponsor institution

Ondokuz Mayıs University

Collaborator